EPIC |
HLN |
Sector |
Pharma and Biotech |
ISIN |
GB00BMX86B70 |
Market Sector |
MAIN |
Market Segment |
SET1 |
Main Indices |
FTSE 100, FTSE 350, FTSE All-Share |
Country of register |
Great Britain |
Currency |
British Pound |
Market Cap |
£32,506m |
NMS |
7,500 |
Shares in issue |
8,957m |
Date Listed |
n/a |
|
Interim |
Final |
Ex-Div |
14-Aug-25 |
24-Apr-25 |
Paid |
18-Sep-25 |
05-Jun-25 |
Amount |
2.20p |
4.60p |
16:47 |
90,761 @ 363.17p |
16:35 |
2,446 @ 362.90p |
16:35 |
116,021 @ 362.90p |
16:35 |
3,765 @ 362.90p |
16:35 |
23,805 @ 362.90p |
CEO |
Brian McNamara |
CFO |
Dawn Allen |
Top of Page
You are here:
research